Trials / NCT00515814
Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptors
Completed N/A Gene therapy, Retinal implant
- Sponsor
- Retina Implant AG
- Treatment
- Retina implant is surgically placed into subretinal position
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to 78 Years
- Enrollment
- 15 participants
- Started
- 2005-09
- Main results expected
- 2009-12
- Results posted
- Not yet
- Record last updated
- 2011-06-09
What the study is testing
The outcome of this trial will reveal the possibilities of the retinal implant to improve the situation of patients with hereditary retinal blindness caused by degenerations of the outer retina. This pilot study will give important information on safety and efficacy of sub-retinal implants.
Where it runs
Germany (2)
- Eye Hospital Dresden-Friedrichstadt, Dresden
- University Eye Hospital Tuebingen, Tübingen